Compositions and methods for detecting stx nucleic acids
AssigneeGen-Probe Incorporated
InventorsPasi M.J. PIIPARINEN, Minna M. MAUNULA
Life of this patent
Estimating the term…
Abstract
Disclosed are nucleic acid oligomers, including amplification oligomers, detection probes, and combinations thereof, for detection of one or more gastrointestinal pathogens expressing shiga toxin (stx). Also disclosed are methods of specific nucleic acid amplification and detection, including multiplex assays, using the disclosed oligomers, as well as corresponding reaction mixtures and kits.
Claims29
A multiplex method for determining the presence or absence one or more variants of a stx target nucleic acid in a sample, said method comprising:
- a. contacting a sample, said sample suspected of containing a stx target nucleic acid with a plurality of stx-specific amplification oligomers for amplifying a target region of the stx target nucleic acid, wherein:
- i. the plurality of stx-specific amplification oligomers comprises first, second, third, fourth, fifth, and sixth oligomers respectively comprising target-hybridizing sequences consisting of the nucleotide sequences of:
- (i) SEQ ID NO:
- 29;
- (ii) SEQ ID NO:
- 5;
- (iii) SEQ ID NO:
- 23;
- (iv) SEQ ID NO:
- 26;
- (v) SEQ ID NO:
- 33;
- and (vi) SEQ ID NO:
- 40;
- ii. the plurality of stx-specific amplification oligomers comprises first, second, third, fourth, and fifth oligomers respectively comprising target-hybridizing sequences consisting of the nucleotide sequences of:
- (i) SEQ ID NO:
- 14;
- (ii) SEQ ID NO:
- 15;
- (iii) SEQ ID NO:
- 18;
- (iv) SEQ ID NO:
- 30;
- and (v) SEQ ID NO:
- 20;
- iii. the plurality of stx-specific amplification oligomers comprises first, second, third, fourth, and fifth oligomers respectively comprising target-hybridizing sequences consisting of the nucleotide sequences of:
- (i) SEQ ID NO:
- 21;
- (ii) SEQ ID NO:
- 19;
- (iii) SEQ ID NO:
- 18;
- (iv) SEQ ID NO:
- 30;
- and (v) SEQ ID NO:
- 20;
- iv. the plurality of stx-specific amplification oligomers comprises first, second, third, fourth, and fifth oligomers respectively comprising target-hybridizing sequences consisting of the nucleotide sequences of:
- (i) SEQ ID NO:
- 31 and;
- (ii) SEQ ID NO:
- 27;
- (iii) SEQ ID NO:
- 18;
- (iv) SEQ ID NO:
- 30;
- and (v) SEQ ID NO:
- 20;
- v. the plurality of stx-specific amplification oligomers comprises first, second, third, fourth, and fifth oligomers respectively comprising target-hybridizing sequences consisting of the nucleotide sequences of:
- (i) SEQ ID NO:
- 36;
- (ii) SEQ ID NO:
- 27;
- (iii) SEQ ID NO:
- 18;
- (iv) SEQ ID NO:
- 30;
- and (v) SEQ ID NO:
- 20;
- or
- vi. the plurality of stx-specific amplification oligomers comprises first, second, third, fourth, fifth, sixth, and seventh oligomers respectively comprising target-hybridizing sequences consisting of the nucleotide sequences of:
- (i) SEQ ID NO:
- 3;
- (ii) SEQ ID NO:
- 4;
- (iii) SEQ ID NO:
- 18;
- (iv) SEQ ID NO:
- 30;
- (v) SEQ ID NO:
- 20;
- (vi) SEQ ID NO:
- 1;
- and (vii) SEQ ID NO:
- 2;
- b. performing an in vitro nucleic acid amplification reaction, wherein the stx target nucleic acid, if present in said sample, is used as a template for generating one or more amplification products corresponding to the stx target regions;
- and
- c. (i) determining the sequences of the one or more amplification products, or (ii) detecting the presence or absence of the one or more amplification products using a plurality of detection probes, wherein the detection probes are specific for one or more variants of the stx target nucleic acid,
- thereby determining the presence or absence of the one or more variants of the stx target nucleic acid in said sample.
7-31. (canceled)
(canceled)
38-41. (canceled)
A set of oligonucleotides for determining the presence or absence one or more variants of a stx target nucleic acid in a sample, said oligonucleotide set comprising a plurality of stx-specific amplification oligomers for amplifying a target region of the stx target nucleic acid, wherein:
- a. the plurality of stx-specific amplification oligomers comprises first, second, third, fourth, fifth, and sixth oligomers respectively comprising target-hybridizing sequences consisting of the nucleotide sequences of:
- (i) SEQ ID NO:
- 29;
- (ii) SEQ ID NO:
- 5;
- (iii) SEQ ID NO:
- 23;
- (iv) SEQ ID NO:
- 26;
- (v) SEQ ID NO:
- 33;
- and (vi) SEQ ID NO:
- 40;
- b. the plurality of stx-specific amplification oligomers comprises first, second, third, fourth, and fifth oligomers respectively comprising target-hybridizing sequences consisting of the nucleotide sequences of:
- (i) SEQ ID NO:
- 14;
- (ii) SEQ ID NO:
- 15;
- (iii) SEQ ID NO:
- 18;
- (iv) SEQ ID NO:
- 30;
- and (v) SEQ ID NO:
- 20;
- c. the plurality of stx-specific amplification oligomers comprises first, second, third, fourth, and fifth oligomers respectively comprising target-hybridizing sequences consisting of the nucleotide sequences of:
- (i) SEQ ID NO:
- 21;
- (ii) SEQ ID NO:
- 19;
- (iii) SEQ ID NO:
- 18;
- (iv) SEQ ID NO:
- 30;
- and (v) SEQ ID NO:
- 20;
- d. the plurality of stx-specific amplification oligomers comprises first, second, third, fourth, and fifth oligomers respectively comprising target-hybridizing sequences consisting of the nucleotide sequences of:
- (i) SEQ ID NO:
- 31 and;
- (ii) SEQ ID NO:
- 27;
- (iii) SEQ ID NO:
- 18;
- (iv) SEQ ID NO:
- 30;
- and (v) SEQ ID NO:
- 20;
- e. the plurality of stx-specific amplification oligomers comprises first, second, third, fourth, and fifth oligomers respectively comprising target-hybridizing sequences consisting of the nucleotide sequences of:
- (i) SEQ ID NO:
- 36;
- (ii) SEQ ID NO:
- 27;
- (iii) SEQ ID NO:
- 18;
- (iv) SEQ ID NO:
- 30;
- and (v) SEQ ID NO:
- 20;
- or
- f. the plurality of stx-specific amplification oligomers comprises first, second, third, fourth, fifth, sixth, and seventh oligomers respectively comprising target-hybridizing sequences consisting of the nucleotide sequences of:
- (i) SEQ ID NO:
- 3;
- (ii) SEQ ID NO:
- 4;
- (iii) SEQ ID NO:
- 18;
- (iv) SEQ ID NO:
- 30;
- (v) SEQ ID NO:
- 20;
- (vi) SEQ ID NO:
- 1;
- and (vii) SEQ ID NO:
- 2.
44-59. (canceled)
61-63. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.